Topical ophthalmic medications: what potential for systemic side effects and interactions with other medications?
All topical ophthalmic agents should be considered potentially potent systemically.
Ivan
I
Goldberg
Gregory
G
Moloney
Peter
P
McCluskey
D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D002319:Cardiovascular System / Q000187:drug effects; D003866:Depressive Disorder / Q000139:chemically induced; D004342:Drug Hypersensitivity / Q000209:etiology; D004347:Drug Interactions; D005901:Glaucoma / Q000150:complications / Q000188:drug therapy; D006801:Humans; D009883:Ophthalmic Solutions; D012137:Respiratory System / Q000187:drug effects
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions